IgA-about the unexpected. by Macpherson, Andrew & Ganal-Vonarburg, Stephanie
INSIGHTS
Rockefeller University Press https://doi.org/10.1084/jem.20181153 1965
J. Exp. Med. 2018 Vol. 215 No. 8 1965–1966
In this issue of JEM, Nakajima et al. (https:// doi .org/ 10 .1084/ jem .20180427) demonstrate that glycan-dependent, epitope-
independent IgA coating of intestinal bacteria alters bacterial gene expression and metabolism. This conferred coated bacteria with 
fitness within the mucus niche and contributed to intestinal homeostasis through cross-phylum interactions.
IgA—about the unexpected
Andrew J. Macpherson and Stephanie C. Ganal‑Vonarburg
IgA may be considered rather a maverick 
among antibody isotypes. Intestinal IgA is 
positioned exactly at the heart of host–mi-
crobial mutualism but risks its integrity in 
the harshest of protease-rich environments. 
It also (partly) departs from the traditional 
idea of immunoglobulin function: that the 
antibody-binding fragments (Fab) com-
posed of one domain each of the heavy and 
light chains provide complementarity to 
bind the antigenic epitope, and the constant 
Fc region of each isotype heavy chain con-
tains the chemical signals that tell the im-
mune system what to do next. In the paper 
by Nakajima et al., glycosyl side chains di-
rect binding to bacterial cell walls, causing 
alterations in bacterial metabolism and the 
ability of IgA-bound taxa to seed benefi-
cial communities of microbes in the outer 
mucus layer of the large intestine (Nakajima 
et al., 2018). The emblematic monoclonal 
studied in their work was highly glyco-
sylated and specific for OVA, which could be 
used to saturate the (Fab) “antigen” binding 
sites without affecting bacterial binding.
Both polymeric secretory IgA and its 
secretory component (SC), the residual 
polypeptide from the polymeric immuno-
globulin receptor (pIgR), which remains 
covalently bound once the secreted IgA has 
been freed by pIgR proteolysis after epi-
thelial transcytosis, are highly glycosylated 
(Mathias and Corthesy, 2011). These carbo-
hydrate chains have been shown to interact 
with pathogenic bacteria either as adhesion 
competitors or by anchoring SIgA to the 
mucus layer to exert a functional protec-
tive effect (Schroten et al., 1998; Royle et al., 
2003). Glycosylation has also been shown 
to allow binding to nonpathogenic bacteria 
by SIgA monoclonals specific for Shigella, 
Salmonella, and respiratory syncytial virus, 
and by isolated SCs (Mathias and Corthesy, 
2011). The glycosyl chains are also protective 
against SIgA proteolysis in the harsh intes-
tinal environment, including by bacterial 
pathogens that secrete specific IgA prote-
ases as a pathogenicity mechanism.
This noncanonical maverick behavior 
of IgA must be taken in context. IgA has 
well-described canonical functions of high 
affinity binding allowing neutralization of 
toxins and viruses, and there is evidence 
that bacterial binding to nonpathogens 
is mediated through the Fab as well as 
through glycosyl interactions (Mathias and 
Corthesy, 2011). The importance of canoni-
cal (Fab) and noncanonical (glycosyl) bind-
ing of microbial molecules by SIgA has so 
far been unclear for a number of the ways 
in which the antibody isotype functions. 
These include limiting exposure of mucosal 
and systemic tissues to taxa of the intestinal 
microbiota (Macpherson and Uhr, 2004), 
delaying the induction of IgA in neonates 
through the protective effect of IgA in the 
maternal milk (Kramer and Cebra, 1995), 
and shaping the ultimate composition of 
the microbiota as neonates are colonized by 
successive waves of microbial taxa before 
reasonable stability of the microbiota is 
achieved (Rogier et al., 2014).
The mammalian microbiota is usually 
presented in terms of its estimated composi-
tion derived from metagenomic sequencing 
data or from the proportions of phylum- or 
genus-specific polymorphisms in the sam-
pled consortia. All learning is an approxi-
mation of the truth: despite considerable 
oro-anal flow along the intestine, taxonomy 
of one site in the intestine gives only limited 
information about the different composi-
tions of microbial taxa in other intestinal 
niches. Equally, knowledge of the genomes 
of different microbial taxa allows infer-
ence of possible overall microbial metabolic 
function in a particular consortium, but 
does not necessarily tell us whether those 
genome-encoded functions are being used 
or not. The paper by Nakajima et al. (2018) 
links noncanonical glycosyl-mediated IgA 
binding to bacteria with its consequences 
on bacterial gene expression in the outer 
mucus layer of the colon and stabilization of 
a healthy microbial consortium.
The outer mucus layer of the colon con-
tains rather dense consortia of intestinal 
microbes, in contrast to the tightly arranged 
mucin polymers of the inner mucus layer, 
which are largely bacteria-free. Previous 
gnotobiotic studies that compared bacte-
rial gene expression and metabolite com-
positions in the outer mucus layer with the 
lumen of the colon have shown that despite 
their proximity, these are two rather dis-
tinct niches (Li et al., 2015).
Recently, the Mazmanian group engi-
neered mutants of Bacteroides fragilis, a 
human commensal, with an altered surface 
capsule, which were better targets for IgA 
binding. This rendered the bacteria more 
competitive and stable within the gut and 
enhanced attachment to intestinal epithelial 
cells shown in vitro. In vivo, the coating with 
IgA seemed to promote location of B. fragilis 
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within the mucus niche. This was confirmed 
with other bacterial strains using IgA-defi-
cient mice (Donaldson et al., 2018).
The observation that IgA binding to com-
mensal bacteria can shift the bacterial gene 
expression to promote survival and homeo-
stasis within the intestine is now consoli-
dated in the paper by Nakajima et al. (2018). 
The authors generated mice whose intesti-
nal IgA was predominantly directed against 
OVA by adoptively transferring OT-II (OVA 
specific) CD4+ T cells into T cell–deficient 
hosts and exposing them to OVA in the 
drinking water. The resulting OVA-specific 
antibodies coated intestinal bacteria but 
could still bind OVA through free Fab sites. 
After generating hybridomas from the small 
intestinal lamina propria cells of these mice, 
a highly glycosylated OVA-specific IgA clone 
was chosen for further experiments. This 
IgA bound different microbial taxa, but 
most efficiently coated Bacteroides thetaio-
taomicron through its LPS: the binding was 
not blocked by OVA, indicating that it did not 
depend on classical Fab epitope interactions.
To see how the 7-6IgA hybridoma would 
function in vivo, a “backpack” experiment 
was performed. 7-6IgA or control hybridoma 
cells were transplanted onto Rag1−/− mice, so 
the recipients expressed a single monoclonal 
(7-6 or control) Ig. When these animals were 
colonized with B. theta after treatment with 
antibiotics, Nakajima et al. (2018) showed 
that although 7-6IgA does not bind directly 
to MAFF, it induced the expression of a 
group of polysaccharide utilization tran-
scripts in B. theta, collectively named Mu-
cus-Associated Functional Factors (MAFFs).
MAFFs are shown to be generally im-
portant in host–microbial mutualism. (1) 
They contribute to in vivo fitness. Other 
commensal Bacteroidales in both mouse 
and humans have orthologous genes that 
are up-regulated in bacteria inhabiting the 
mucus niche. Deletion of two B. theta MAFF 
genes (ΔmaffC and ΔmaffD) caused growth 
retardation in minimal medium in vitro and 
reduced fitness in mouse competition as-
says in vivo, including smaller size than the 
wild-type strain. Induction of MAFF genes 
seemed to enhance the ability of B. theta to 
use dietary carbohydrates. (2) MAFFs deter-
mine the phenotype of B. theta in the pres-
ence of other taxa. The larger size of B. theta 
wild-type compared with the Δmaff strain 
is lost in germ-free mice, even when the 
wild-type strain was small, indicating that 
the size effect of the MAFF gene function in 
vivo depends on the presence of a diverse 
microbiota, possibly through cross-feed-
ing. (3) MAFF function can influence the 
composition of other taxa in the microbiota 
and the resilience of the host to inflamma-
tory challenges. Colonization of antibiot-
ic-treated specific pathogen-free mice with 
the wild-type B. theta strain compared with 
the Δmaff double mutant increased the 
abundance of Clostridiales and the gene ex-
pression profile of Firmicutes, resulting in 
protection from chemically induced colitis 
with higher short-chain fatty acid produc-
tion. The beneficial effects on microbiota 
composition appear to be enhanced in the 
7-6IgA backpack model. Hence, the data 
of Nakajima et al. (2018) highlight the role 
of epitope-independent, glycan-mediated 
binding of IgA to bacteria followed by induc-
tion of MAFF genes. This promotes bacterial 
fitness within the outer mucus layer and in-
terphylum interactions among commensal 
bacteria, improving intestinal homeostasis.
Gordon and colleagues have previously 
shown beneficial effects of monoclonal IgA 
in a similar backpack model using B. theta 
monocolonized Rag−/− mice carrying a hy-
bridoma for a specific polysaccharide cap-
sular epitope. Here, the loss of binding was 
highly specific according to the particular 
capsular polysaccharide gene locus that was 
disrupted in a transposon screen, and an 
acid hydrolysis–sensitive epitope could be 
extracted for binding studies. Specific IgA 
binding to this B. theta epitope limited in-
nate immune responses in the host intestine 
and protected the bacterium from oxidative 
stress (Peterson et al., 2007). The group has 
subsequently reported another IgA mono-
clonal against the LPS O-Ag polysaccharide 
that can also modulate bacterial gene ex-
pression in vivo (Peterson et al., 2015).
These experiments start to dissect the 
multidimensional interplay between IgA 
binding to intestinal microbes, bacterial 
metabolism, innate responses of the muco-
sal immune system, niche occupancy within 
the outer mucus layer, and interactions with 
other commensals. They also illustrate that 
nonconventional binding and amplification 
of natural specificities (Bunker et al., 2017) 
may be sufficient for IgA function. Despite 
the elegance of these experiments, they are 
likely facets of a much bigger picture. Just as 
alternative behavior of mavericks is often 
successful in business, perhaps reducing 
IgA canonical binding constraints is part 
of its secret of success and can be exploited 
therapeutically, such as modulation of the 
microbiota to protect premature infants 
from necrotizing enterocolitis.
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